Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis

Journal of Hepatology

Volumn 53, Issue 1, 2010, Pages 25-35

  Sturm, Nathalie ^a,b,c   Thélu, Marie Ange ^a,b   Camous, Xavier ^a,b   Dimitrov, Guéorgui ^a,b   Ramzan, Muhammad ^a,b   Dufeu Duchesne, Tania ^a,b   Bonorino, Paula ^a,b   Guillermet, Christiane ^b,c   Brambilla, Elisabeth ^a,b,c   Arvers, Philippe ^d   Pernollet, Martine ^a,b   Leroy, Vincent ^a,b   Zarski, Jean Pierre ^a,b   Marche, Patrice N ^a,b   Jouvin Marche, Evelyne ^a,b  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

^d CENTRE DE RECHERCHES   (France)

Author keywords

FoxP3; Hepatitis C virus (HCV); Immunohistochemistry; Liver; Regulatory T cells; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; FORMALDEHYDE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; PRIMER DNA;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; FROZEN SECTION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; GENETICS; HEPATITIS C, CHRONIC; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA PRIMERS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 77953230741     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.02.024     Document Type: Article

References (47)

1. Barnes E., Harcourt G., Brown D., Lucas M., Phillips R., Dusheiko G., et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36 (2002) 743-754
2. He X.S., Rehermann B., Lopez-Labrador F.X., Boisvert J., Cheung R., Mumm J., et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96 (1999) 5692-5697
3. Wedemeyer H., He X.S., Nascimbeni M., Davis A.R., Greenberg H.B., Hoofnagle J.H., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169 (2002) 3447-3458
4. Grabowska A.M., Lechner F., Klenerman P., Tighe P.J., Ryder S., Ball J.K., et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol 31 (2001) 2388-2394
5. Leroy V., Vigan I., Mosnier J.F., Dufeu-Duchesne T., Pernollet M., Zarski J.P., et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 38 (2003) 829-841
6. Spangenberg H.C., Viazov S., Kersting N., Neumann-Haefelin C., McKinney D., Roggendorf M., et al. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42 (2005) 828-837
7. Burton Jr. J.R., Klarquist J., Im K., Smyk-Pearson S., Golden-Mason L., Castelblanco N., et al. Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J Hepatol 49 (2008) 329-338
8. Dustin L.B., and Rice C.M. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 25 (2007) 71-99
9. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., and Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194 (2001) 1395-1406
10. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
11. Cabrera R., Tu Z., Xu Y., Firpi R.J., Rosen H.R., Liu C., et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40 (2004) 1062-1071
12. Hesse M., Piccirillo C.A., Belkaid Y., Prufer J., Mentink-Kane M., Leusink M., et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172 (2004) 3157-3166
13. MacDonald A.J., Duffy M., Brady M.T., McKiernan S., Hall W., Hegarty J., et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 185 (2002) 720-727
14. McKee A.S., and Pearce E.J. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 173 (2004) 1224-1231
15. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
16. Claassen M., de Knegt R., Turgut D., Groothuismink A., Jansen H., and Boonstra A. Role of multiple regulatory T cell populations in controlling peripheral blood and liver immunity to human hepatitis C virus infections. Eur J Immunol 39 (2009) S590
17. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
18. Sugimoto K., Ikeda F., Stadanlick J., Nunes F.A., Alter H.J., and Chang K.M. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38 (2003) 1437-1448
19. Dittmer U., He H., Messer R.J., Schimmer S., Olbrich A.R., Ohlen C., et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20 (2004) 293-303
20. Rushbrook S.M., Ward S.M., Unitt E., Vowler S.L., Lucas M., Klenerman P., et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79 (2005) 7852-7859
21. Kim J.M., and Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212 (2006) 86-98
22. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 24 (2006) 209-226
23. Ebinuma H., Nakamoto N., Li Y., Price D.A., Gostick E., Levine B.L., et al. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 82 (2008) 5043-5053
24. Li S., Gowans E.J., Chougnet C., Plebanski M., and Dittmer U. Natural regulatory T cells and persistent viral infection. J Virol 82 (2008) 21-30
25. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
26. Bienvenu B., Martin B., Auffray C., Cordier C., Becourt C., and Lucas B. Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 175 (2005) 246-253
27. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
28. Billerbeck E., Blum H.E., and Thimme R. Parallel expansion of human virus-specific FoxP3- effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J Immunol 179 (2007) 1039-1048
29. Bonorino P., Ramzan M., Camous X., Dufeu-Duchesne T., Thelu M.A., Sturm N., et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 51 (2009) 458-467
30. Bonorino P., Leroy V., Dufeu-Duchesne T., Tongiani-Dashan S., Sturm N., Pernollet M., et al. Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C. Hepatology 46 (2007) 1375-1386
31. Pernollet M., Jouvin-Marche E., Leroy V., Vigan I., Zarski J.P., and Marche P.N. Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions. Clin Exp Immunol 130 (2002) 518-525
32. Vigan I., Jouvin-Marche E., Leroy V., Pernollet M., Tongiani-Dashan S., Borel E., et al. T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity. J Hepatol 38 (2003) 651-659
33. Bisikirska B., Colgan J., Luban J., Bluestone J.A., and Herold K.C. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 115 (2005) 2904-2913
34. Endharti A.T., IMs Rifa., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175 (2005) 7093-7097
35. Noble A., Giorgini A., and Leggat J.A. Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 107 (2006) 4475-4483
36. Franceschini D., Paroli M., Francavilla V., Videtta M., Morrone S., Labbadia G., et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119 (2009) 551-564
37. Stoop J.N., Claassen M.A., Woltman A.M., Binda R.S., Kuipers E.J., Janssen H.L., et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 129 (2008) 419-427
38. Ward S.M., Fox B.C., Brown P.J., Worthington J., Fox S.B., Chapman R.W., et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47 (2007) 316-324
39. Abel M., Sene D., Pol S., Bourliere M., Poynard T., Charlotte F., et al. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44 (2006) 1607-1616
40. Billerbeck E., and Thimme R. CD8+ regulatory T cells in persistent human viral infections. Hum Immunol 69 (2008) 771-775
41. Bolacchi F., Sinistro A., Ciaprini C., Demin F., Capozzi M., Carducci F.C., et al. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144 (2006) 188-196
42. Schuppan D., Krebs A., Bauer M., and Hahn E.G. Hepatitis C and liver fibrosis. Cell Death Differ 10 (2003) S59-67
43. Uraushihara K., Kanai T., Ko K., Totsuka T., Makita S., Iiyama R., et al. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J Immunol 171 (2003) 708-716
44. Hassan M., Selimovic D., Ghozlan H., and Abdel-Kader O. Induction of high-molecular-weight (HMW) tumor necrosis factor (TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation. Cell Signal 19 (2007) 301-311
45. McGuinness P.H., Painter D., Davies S., and McCaughan G.W. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46 (2000) 260-269
46. Migita K., Abiru S., Maeda Y., Daikoku M., Ohata K., Nakamura M., et al. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 67 (2006) 27-32
47. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79 (2005) 7860-7867